Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.47 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Restructuring Costs (2013)

Updated

Protagenic Therapeutics, Inc.new (PTIX) posted Restructuring Costs of -$204,000 for FY2014 (year ended Jun 30, 2014), compared with -$221,000 in FY2013.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Restructuring Costs (2013) Analysis & Trends

  • Business Quant data shows PTIX's Restructuring Costs at -$221,000 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,300.96 Bn 1,274.58 Bn 20.46 Bn
2 Johnson & Johnson 691.57 Bn 611.43 Bn 17.30 Bn
3 AbbVie 526.86 Bn 494.87 Bn 13.12 Bn
4 Merck 365.17 Bn 328.11 Bn 13.19 Bn
5 Novartis Ag 314.51 Bn 287.74 Bn -
6 Astrazeneca 288.94 Bn 262.45 Bn 13.26 Bn
7 Amgen 254.33 Bn 205.98 Bn 7.58 Bn
8 Gilead Sciences 211.53 Bn 186.64 Bn 6.73 Bn
9 Pfizer 166.13 Bn 113.48 Bn 12.56 Bn
10 Protagenic Therapeutics, Inc.new 850,797.76 -3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 -204,000.00
API Access

Protagenic Therapeutics, Inc.new Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=PTIX&period=max&api_key=YOUR_API_KEY